chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female patient with latex allergy who on an unspecified date was vaccinated with a dose of GARDASIL (lot # not reported). Suspect secondary therapy included DTaP (unspecified) (manufacturer unknown). On an unspecified date the patient experienced anaphylactic reaction after receiving multiple vaccines including GARDASIL. Follow up information has been received on 09-APR-2010 via telephone call from a physician who was peripherally involved in this case. He explained that the patient's primary care physician (PCP) had consulted him because he was an allergist. The physician stated that he had originally called to inquire the GARDASIL "components". The physician stated that GARDASIL was definitely not involved in this report. The physician refused to give the patient's primary care physician name or contact information. The physician refused to given the patient's primary care physician name or contact information. The physician stated that he suspected that a DTaP (manufacturer unknown) vaccine was related to the patient's anaphylactic reaction. The DTaP (manufacturer unknown) had a latex stopper and the patient was allergic to latex. The patient had recovered. It was unknown if the patient sought medical attention. Additional information is not expected.
Within 2-3 hours post vaccination severe nausea, vomiting, diarrhea, dizzy, lightheaded very extreme today rather sluggish.
Pain/It's even worse than the second dose and it's been ongoing for almost two weeks"; Crumps; Had crumps and pain and the reporter stated that it was even worse than the second dose; Arm is swollen; Had a fever before but now was gone; Lymph nodes under her arm and left side are swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain/It's even worse than the second dose and it's been ongoing for almost two weeks"), MUSCLE SPASMS (Crumps), CONDITION AGGRAVATED (Had crumps and pain and the reporter stated that it was even worse than the second dose), PERIPHERAL SWELLING (Arm is swollen) and PYREXIA (Had a fever before but now was gone) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain/It's even worse than the second dose and it's been ongoing for almost two weeks"), MUSCLE SPASMS (Crumps), CONDITION AGGRAVATED (Had crumps and pain and the reporter stated that it was even worse than the second dose), PERIPHERAL SWELLING (Arm is swollen), PYREXIA (Had a fever before but now was gone) and LYMPHADENOPATHY (Lymph nodes under her arm and left side are swollen). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN (Pain/It's even worse than the second dose and it's been ongoing for almost two weeks"), MUSCLE SPASMS (Crumps), CONDITION AGGRAVATED (Had crumps and pain and the reporter stated that it was even worse than the second dose), PERIPHERAL SWELLING (Arm is swollen) and LYMPHADENOPATHY (Lymph nodes under her arm and left side are swollen) had not resolved and PYREXIA (Had a fever before but now was gone) had resolved.            The reporter was calling on behalf of their daughter who was the patient and reported that post receiving the booster dose, the patient was swollen; their lymph nodes under their arm and left side were swollen, as well as their arm. The patient had a fever before but now was gone. Reportedly, the patient also had crumps and pain and the reporter stated that it was even worse than the second dose and it had been ongoing for almost two weeks. The pharmacist told them to use Benadryl, but the reporter stated that they've tried with Aspirin and other pills too.  The reporter also informed that the patient was born in 1981 and had 39 when they had their 2nd dose, and was 40 year old now.  No Concomitant product use was reported. Treatment medication reported also included some other pills for unknown indication.   This case was linked to MOD-2021-402764 (Patient Link).
Extremely itchy hives all over body, starting in back of scalp and spreading all over body.  I am going into the eighth week with this.
tired feeling; 100°F temperature for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE ABNORMAL (100°F temperature for 24 hours) and FATIGUE (tired feeling) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced FATIGUE (tired feeling). On an unknown date, the patient experienced BODY TEMPERATURE ABNORMAL (100°F temperature for 24 hours). At the time of the report, BODY TEMPERATURE ABNORMAL (100°F temperature for 24 hours) and FATIGUE (tired feeling) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (abnormal) 100 degree Fahrenheit for 24 hours..         Patient didn't had allergies. Concomitant medication was not reported. Patient had not tested COVID-19 positive previously. Treatment medication was not reported.   This case was linked to MOD-2022-544448 (Patient Link).   Reporter did not allow further contact
RASH ON RIGHT LEG; This spontaneous report received from a consumer concerned a 70 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on left arm on 26-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced rash on right leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rash on right leg was not reported. This report was non-serious.
COVID positive on 7/11/2021 in hospital Acute RUQ pain, congestion, and fever Currently hospitalized.
Headache.  Labyrinthitis. Developed headache & vertigo 48 hrs after vaccination.  Hospitalized.  Acute labyrinthitis diagnosed.
Patient has had an all over body rash  since the first vaccine. She has self treated with benadryl and hydrocortisone and it has not gone away. RPH advised her not to receive dose #2 and to seek medical attention
Swollen lymph nodes and abdominal pain from right him bone down to scrotum. Pain on 4/7 was such that i though i was suffering a hernia.  Couldn't get out of car or move my right leg across my body. Could put right leg into pants leg.  Hurt to bend over and do much of anything on 4/7.   Initially thought pain was in testicle but doesn't hurt at all to the touch.  Realized it more a swollen area in the groin between hip bone and scrotum.   Nothing hurts to the touch at all in that area either which lead my to believe it was swollen lymph nodes.  The  Feeling is as if i got hit in the right groin  and my testicle has been hit and discomfort is 8 inches above right testicle in my groin area.    It has been improving every day since then, the more i walk the better it is.  It only hurts when i sit now and it seems to aggravate it pretty well but once i start moving the pain goes away.  It has been 9 days now and the i don't notice it all day until i come back to the office and sit at my desk and again it gets aggravated and the discomfort feels like my right testicle is near my appendix  Since this all started my legs feel heavier in the calf and have little nerve sensations when i sit too, which concerns me about the blood clot possibility and so i have been emailing with my doctor.  I am going to make appt for Monday 4/19
my heart is skipping/it stops beating for a second; Inappropriate schedule of vaccine administered; fever; This spontaneous case was reported by a consumer and describes the occurrence of EXTRASYSTOLES (my heart is skipping/it stops beating for a second), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and PYREXIA (fever) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 003A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUTICASONE for an unknown indication.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced EXTRASYSTOLES (my heart is skipping/it stops beating for a second). an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, EXTRASYSTOLES (my heart is skipping/it stops beating for a second) and PYREXIA (fever) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.       Treatment information was not provided.   This case was linked to MOD-2021-291503 (Patient Link).
This case was reported by a consumer via call center representative and described the occurrence of feeling cold in a 80-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of chills (1st dose received in May 2018 (see case US2018GSK149565)). On 8th August 2018 09:00, the patient received the 2nd dose of SHINGRIX. On 8th August 2018 18:00, 9 hrs after receiving SHINGRIX, the patient experienced feeling cold, shivering, headache, fever, general body pain, tingling of extremity and grip strength decreased. On an unknown date, the outcome of the feeling cold, shivering, headache, fever, tingling of extremity and grip strength decreased were recovered/resolved and the outcome of the general body pain was not recovered/not resolved. It was unknown if the reporter considered the feeling cold, shivering, headache, fever, general body pain, tingling of extremity and grip strength decreased to be related to SHINGRIX. Additional details were provided as follows: The patient had same experience as of 1st dose but the symptoms were worse for this dose. The patient thought she had to go to the emergency room because she had a temperature of 102.5 with shivering, headache and body aches. This case was linked with US2018GSK149565, reported by the same reporter.
motion was more difficult; experiencing 100.9 Temperature; arm was sore; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at the age of 60-year-old, via an unspecified route of administration, administered in left arm on 04Mar2021 12:45 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included asthma. Concomitant medication included other medications (unspecified) in two weeks. No other vaccine in four weeks. The patient has known allergies to morphine. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVOD-19 post vaccination. The patient experienced arm was sore on 05Mar2021 14:00. The motion was more difficult and experiencing 100.9 temperature on 05Mar2021 16:45 (reported as after 28 hours). The patient did not received treatment for the events. The patient recovered from the events on an unspecified date. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Gout were off worse; Worse balance; Fatigue level was higher/fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Gout were off worse), BALANCE DISORDER (Worse balance), FATIGUE (Fatigue level was higher/fatigue) and HEADACHE (Headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 078C21A and 051C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 22-Mar-2021. Concurrent medical conditions included Multiple sclerosis since 01-Jun-2008. Concomitant products included BACLOFEN, AMPYRA, TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), MYRBETRIQ, PROVIGIL, CRESTOR, SINGULAIR, TELMISARTAN, DILTIAZEM, ONGLYZA, ATIVAN, ALBUTEROL, VITAMIN D, CALCIUM, SAW PALMETTO [SERENOA REPENS], METHOTREXATE, RITUXIMAB (RITUXAN) and METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) for an unknown indication.   On 30-Jun-2021 at 7:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021 at 2:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jul-2021 at 10:00 PM, the patient experienced GOUT (Gout were off worse), BALANCE DISORDER (Worse balance), FATIGUE (Fatigue level was higher/fatigue) and HEADACHE (Headache). On 30-Jul-2021, GOUT (Gout were off worse), BALANCE DISORDER (Worse balance), FATIGUE (Fatigue level was higher/fatigue) and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered GOUT (Gout were off worse), BALANCE DISORDER (Worse balance), FATIGUE (Fatigue level was higher/fatigue) and HEADACHE (Headache) to be possibly related.    No treatment information was provided by the reporter.   This case was linked to MOD-2021-244820 (Patient Link).
3-4 hot welts on left arm near injection; 3-4 hot welts on left arm near injection; This is a spontaneous report from a contactable consumer (patient). A 44-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 20Mar2021 09:15 (Batch/Lot Number: Ep7534) as SINGLE DOSE for covid-19 immunisation.The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received bnt162b2 (BNT162B2) dose 1 via an unspecified route of administration, administered in Arm Left on 27Feb2021 10:30 AM (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination The patient experienced 3-4 hot welts on left arm near injection on 22Mar2021 at 08:00 AM. No treatment was received for the events. The events were assessed as non-serious by the reporter. Outcome of the events were not recovered.
Patient scheduled for second dose of COVID Vaccine during a Pfizer only clinic day. Side effects of Pfizer reviewed and patient had no questions. Although she wrote she is best served in both English and Spanish, we conversed in English and she stated she was fine when asked if needed a translator. Patient observed for 15 minutes. Patient tolerated well. Upon entering COVID vaccine worksheet in the EMR, it was noticed that her first dose given was Moderna. Immediately contacted Supervisor, Pharmacy Director and proceeded to research latest findings on CDC and WHO site. Both sites state although the vaccines are not interchangeable and effectiveness has not been thoroughly studied and researched, they are similar enough to not suspect a safety concern and additional doses of either are not needed. Vaccine administered by LPN.
Information has been received from a physician concerning a 73 year old female who on 10/22/03 was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine (lot # 647654/0865N). P1: just one year ago (Physician reported that he does not know why patient got second dose so close to the first"). Subsequently the patient developed significant local and systemic (fever and joint pain) reactions. The physician indicated that the patient was not hospitalized, but she was treated with ceftriaxone sodium. No additional information was provided. Unspecified medical attention was sought. There was no product quality complaint. Follow up information from the physician indicated that he was only covering the office for 48 hours and he believes both were significant local reactions which did not require further treatment. Upon internal review, the significant local and systemic (fever and joint pain) reactions were considered to be other important medical events (OMIC). The reporter also indicated that one other patient was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot # 647654/0865N) and developed a similar reaction. Additional information has been requested.
Information has been received from a 71-year-old male consumer with hypertension and no allergies, who on 23-JUL-2007 was vaccinated with a 0.65 milliliter dose of Zostavax (Oka/Merck).  Concomitant therapy included unspecified hypertension medication.  On 24-JUL-2007 the patient experienced hives on his right side above his waist and total body itchiness.  It is reported that the patient is not sure if he ever had chickenpox.  No medical attention was sought.  There were no laboratory or diagnostic tests performed.  The outcome is reported as not recovered.  No product quality complaint was involved.  Additional information is not expected.
So I got up from the chair to go to the other room to be on the 15 min observation. I started feeling a little weird within a minute. A sharp shooting numbness in my jaw and my head felt a little dizzy, and a burst of heat in my spine. I felt off and sat down and took my BP and my BP was 185/80. Within a couple of minutes I was at the walk in clinic where they monitored me for a couple of hours. The jaw experience went away but I still felt a little shaky. I also had a numbness/tingling in the face and jaw. They gave me a Benadryl injection and it did not resolve. They gave me prednisone it felt a little better (about 30min) afterwards. They checked my airways and it was ok. I had elevated BP but within a couple of hours it was ok . They discharged me since I felt ok and a friend drove me home. Symptoms were better next day but in the afternoon I felt the numbness again on my lips. They decided to prescribe me medro and I started taking it since Friday evening. I still feel a little head ache and like I am a little sick. The headache is still lingering. Left side of my face since yesterday I have a stiff neck. It is like a pain in my face.
Within minutes of vaccination, I had problems with swelling lips and itchy throat.  My airway became impaired.  IV Benadryl was administered immediately as I was in an acute care setting
I received the 2nd SHINGRIX shot. 30 hours later I became ill: Cramps, diarrhea, vomiting and shivering.
Patient arrived to receive booster vaccine and Pfizer pediatric vaccine was accidentally given instead of Pfizer adult vaccine. We followed up with patient, and no side effects were reported
ONe week after injection patient woke up with swollen left arm below injection site of 4 1/2 x 4 1/2 inch slightly raised red itchy area.
This medically confirmed report (initial receipt 08-Oct-2014) concerns an 81 year old female patient who had a medical history of tape allergy (redness), lung cancer diagnosed in Dec-2011. The patient received a right lower lobectomy and pathology revealed a 1.9cm adenocarcinoma that was invading the visceral pleura with a negative margin. The patient had 3/8 peribronchial lymph nodes positive for metastatic adenocarcinoma. Molecular testing revealed ALK translocation. On the 26-Mar-2012, the patient completed 4 cycles of adjuvant carboplatin and ALIMTA. In May-2014, the patient had a PET (Positron emission tomography) and CT (Computerised Tomography) scan that showed extensive mediastina and hilar uptake and additional several bone lesions were identified. On the 04-Jun-2014, a FNA of paratracheal node confirmed metastatic N5CLC-Adeno with ALK mutation. Concomitant medications included risedronate 150mg monthly, zolpidem (5 mg and 6.25 mg extended release) when required for sleep, ondansetron 4mg orally when required for nausea, vomiting. Other documented medications included 'Bone Strength Take Care' 3000mg orally daily, iron 28mg orally daily, krill oil 1 capsule orally daily and levothyroxine 25 mcg orally daily. On the 26-Jun-2014, the patient commenced crizotinib, 200 mg twice daily orally. On the 28-Aug-2014, the patient presented for a regular follow up. The patient reported that for the last four to five days, she was having watery diarrhoea (with no blood or mucus) several times a day. The week prior, she was constipated and was advised to take magnesium citrate, polyethylene glycol and senna. After taking these medications, she developed diarrhoea. Two weeks prior, the patient developed worsening fatigue, LE (left) edema had increased over the past few weeks. The patient denied fever, chills, hemoptysis and headaches. The patient reported poor appetite. On the 09-Sep-2014, the patient received the influenza vaccine (manufacturer and batch number not reported) and concomitantly received Pneumococcal vaccine (manufacturer and batch number not provided), tetanus vaccine (manufacturer and batch number not provided) and zoster vaccine (manufacturer and batch number not provided). On an unspecified date, the patient developed nausea, some weight loss, at times taste loss, heart was somewhat enlarged and ankles were swollen. Outcome was reported as recovering.
later in evening, high pitched, shrill cry off & on during evening;restless not crying like himself-throught about taking to MD but didn't;gave APAP q 4 hrs x 24 hrs;
PATIENT REPORTED FLU-LIKE SYMPTOMS AND THE SMALL RASH HE HAD PRIOR (WAS NOT REPORTED TO RPH UNTIL AFTER SHOT) GOT WORSE FOR UP TO 2 DAYS AFTER INJECTION. HE DID HAVE SHINGLES IN PAST. HE SAID THIS TIME IT WAS LIKE SHINGLES BUT MORE MILD, SHORTER DURATION OF SYMPTOMS. HE SAID LASTED ABOUT 2 DAYS AND HE WAS ALSO SORE AT INJECTION SITE.
Information has been received on 20-APR-2017 from a lawyer regarding a case in litigation concerning a male patient who was inoculated with ZOSTAVAX on or about 08-JUL-2013 at a Care Center, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. On or about 13-DEC-2013, the patient was treated at a clinic for an ongoing painful rash which was diagnosed as shingles and post herpetic neuralgia, a condition involving nerve damage as a residual effect of severe shingles. Although shingles and post herpetic neuralgia are incurable conditions, the patient was prescribed NEURONTIN and amitriptyline, for management his symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
pt felt tired and unwell later in the day after receiving injection. body aches started  the next day. she was hospitalized 11/21/21-11/29/21 at hospital for covid pneumonia. she was given remdesivir and dx'd with kidney damage and symptoms worsened with treatment. she was discharged and returned to same ER 12/14/21 for facial and neck swelling.  went to ER 12/27/21 arm pain and numbness.